CX3CR1 and cancer: Understanding how TGF-β1 impairs the expression of CX3CR1 in CD56dim NK has potential clinical implications, since it could improve the current knowledge of the mechanisms that regulate the immune responses and, in cancer, participate in the escape from immune surveillance.